NCT07107074: Effects of a Widely Used Vaccine Adjuvant in Subjects With Early Alzheimer's Disease Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients With Early Alzheimer's Disease - ADVANCE
- State
- Under way
- Phase
- Phase 2
- People
- 122 planned
- Started
- 8 Nov 2023
- Primary completion
- Dec 2026
- Arms
- 1ml AD04
- Results
- None posted
- 8 Nov 2023: Trial started
- 6 Aug 2025: Trial registered